Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance

Epigenomics

Volumn 6, Issue 2, 2014, Pages 193-207

  Desgagné, Véronique ^a,b   Hivert, Marie France ^c,d   St Pierre, Julie ^b,e   Guay, Simon Pierre ^a,b   Baillargeon, Jean Patrice ^c   Perron, Patrice ^b,c   Gaudet, Daniel ^b,f   Brisson, Diane ^b,f   Bouchard, Luigi ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b CHICOUTIMI HOSPITAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

DNA methylation; gestational diabetes; IGF; mRNA; placenta

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN RECEPTOR; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; GLUCOSE BLOOD LEVEL; IGF1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; INSR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; COHORT ANALYSIS; DIET RESTRICTION; DNA METHYLATION; EPIGENETIC DYSREGULATION; EPIGENETICS; FEMALE; FETUS GROWTH; GENETIC REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; PLACENTA; PLACENTA WEIGHT; PREGNANCY; PRIORITY JOURNAL; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT GAIN; BIOSYNTHESIS; GENETIC EPIGENESIS; GENETICS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; PATHOPHYSIOLOGY;

ADULT; ANTIGENS, CD; BLOOD GLUCOSE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PLACENTA; PREGNANCY; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RNA, MESSENGER;

EID: 84900402434     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.3     Document Type: Article

References (45)

1. Canadian Diabetes Association. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 32(Suppl. 1), S168-S180 (2008).
2. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, Mcduffie RS. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28(3), 579-584 (2005). (Pubitemid 40315316)
3. Barker DJ. Fetal origins of cardiovascular disease. Ann. Med. 31(Suppl. 1), 3-6 (1999). (Pubitemid 29209697)
4. Kaaja R, Ronnemaa T. Gestational diabetes: pathogenesis and consequences to mother and offspring. Rev. Diabet. Stud. 5(4), 194-202 (2008).
5. Forbes K, Westwood M. The IGF axis and placental function: a mini review. Horm. Res. 69(3), 129-137 (2008). (Pubitemid 351161040)
6. Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J. Anat. 215(1), 60-68 (2009).
7. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta 24(8-9), 803-812 (2003). (Pubitemid 37184807)
8. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of 'metabolic memory'. Exp. Diabetes Res. 2011, 218-598 (2011).
9. St-Pierre J, Hivert MF, Perron P et al. IGF2 DNA methylation is a modulator of newborn's fetal growth and development. Epigenetics 7(10), 1125-1132 (2012).
10. Henikoff S, Matzke MA. Exploring and explaining epigenetic effects. Trends Genet. 13(8), 293-295 (1997).
11. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.), 245-254 (2003). (Pubitemid 36278835)
12. Kangaspeska S, Stride B, Metivier R et al. Transient cyclical methylation of promoter DNA. Nature 452(7183), 112-115 (2008). (Pubitemid 351355094)
13. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16(1), 6-21 (2002). (Pubitemid 34049633)
14. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 321(6067), 209-213 (1986). (Pubitemid 16016411)
15. Ruchat SM, Houde AA, Voisin G et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 8(9), 935-943 (2013).
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539-553 (1998). (Pubitemid 28319935)
17. Lacroix M, Battista MC, Doyon M et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36(6), 1577-1583 (2013).
18. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics Books (1988).
19. Marsh S. Pyrosequencing applications. Methods Mol. Biol. 373, 15-24 (2007).
20. Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26(8-9), 601-607 (2005). (Pubitemid 41102682)
21. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP, Kalionis B. GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 29(9), 798-801 (2008).
22. Drewlo S, Levytska K, Kingdom J. Revisiting the housekeeping genes of human placental development and insufficiency syndromes. Placenta 33(11), 952-954 (2012).
23. Dube MP, Schmidt S, Hauser E et al. Multistage designs in the genomic era. providing balance in complex disease studies. Genet. Epidemiol. 31(Suppl. 1), S118-S123 (2007).
24. Glaser RL, Ramsay JP, Morison IM. The imprinted gene and parent-of-origin effect database now includes parental origin of de novo mutations. Nucleic Acids Res. 34(Database issue), D29-D31 (2006).
25. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30(Suppl. 2), S141-S146 (2007). (Pubitemid 47036416)
26. Herbstman JB, Wang S, Perera FP et al. Predictors and consequences of global DNA methylation in cord blood and at three years. PLoS ONE 8(9), e72824 (2013).
27. Liu X, Chen Q, Tsai HJ et al. Maternal preconception body mass index and offspring cord blood DNA methylation: exploration of early life origins of disease. Environ. Mol. Mutagen. doi:10.1002/em.21827 (2013) (Epub ahead of print).
28. Ludwig DS, Rouse HL, Currie J. Pregnancy weight gain and childhood body weight: a within-family comparison. PLoS Med. 10(10), e1001521 (2013).
29. Koukoura O, Sifakis S, Soufla G et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int. J. Mol. Med. 28(4), 481-487 (2011).
30. Holly JM, Perks CM. Insulin-like growth factor physiology: what we have learned from human studies. Endocrinol. Metab. Clin. North Am. 41(2), 249-263, v (2012).
31. Weaver JR, Susiarjo M, Bartolomei MS. Imprinting and epigenetic changes in the early embryo. Mamm. Genome 20(9-10), 532-543 (2009).
32. Bowman CJ, Streck RD, Chapin RE. Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development. Birth Defects Res. B Dev. Reprod. Toxicol. 89(4), 339-349 (2010).
33. Forbes K, Westwood M. Maternal growth factor regulation of human placental development and fetal growth. J. Endocrinol. 207(1), 1-16 (2010).
34. Jiang H, Xun P, Luo G et al. Levels of insulin-like growth factors and their receptors in placenta in relation to macrosomia. Asia Pac. J. Clin. Nutr. 18(2), 171-178 (2009).
35. Osorio M, Torres J, Moya F et al. Insulin-like growth factors (IGFs) and IGF binding proteins-1,-2, and-3 in newborn serum. relationships to fetoplacental growth at term. Early Hum. Dev. 46(1-2), 15-26 (1996). (Pubitemid 26341113)
36. Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6- phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J. Clin. Endocrinol. Metab. 85(11), 4266-4269 (2000). (Pubitemid 32055384)
37. Yamada PM, Lee KW. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am. J. Physiol. Cell Physiol. 296(5), C954-976 (2009).
38. Jansson T, Aye IL, Goberdhan DC. The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta 33(Suppl. 2), e23-e29 (2012).
39. Issa JP. Age related variation in DNA methylation. In: Epigenetic Epidemiology. Michels KB (Ed.). Springer Science & Business Media BV, Dordrecht, The Netherlands, 185-196 (2012).
40. Oberdoerffer S. A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing. Transcription 3(3), 106-109 (2012).
41. Satagopan JM, Venkatraman, ES, Begg CB. Two-stage designs for genedisease association studies with sample size constraints. Biometrics 60(3), 589-597 (2004). (Pubitemid 39181102)
42. Sobell JL, Heston LL, Sommer SS. Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene. Am. J. Med. Genet. 48(1), 28-35 (1993). (Pubitemid 23119954)
43. Konig IR, Ziegler A. Group sequential study designs in geneticepidemiological case-control studies. Hum. Hered. 56(1-3), 63-72 (2003). (Pubitemid 37465072)
44. Bender R, Lange S. Adjusting for multiple testing-when and how? J. Clin. Epidemiol. 54(4), 343-349 (2001).
45. Talens RP, Boomsma DI, Tobi EW et al. Variation, patterns, and temporal stability of DNA methylation. considerations for epigenetic epidemiology. FASEB J. 24(9), 3135-3144 (2010).